The latest quarterly R&D expense is $8.21 Million with a QoQ Growth of -2.33%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $8.21M.
$8.21M
$8.21 Million
Q2 FY2026 · 2026-06-30
-2.33%
vs. $8.40M prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $8.21M | -2.33% | -37.07% |
| Q1 FY2026Period end 2026-03-31 | $8.40M | -5.23% | -33.13% |
| Q4 FY2025Period end 2025-12-31 | $8.87M | +6.79% | +23.30% |
| Q3 FY2025Period end 2025-09-30 | $8.30M | -36.34% | +113.22% |
| Q2 FY2025Period end 2025-06-30 | $13.04M | +3.79% | +168.25% |
| Q1 FY2025Period end 2025-03-31 | $12.56M | +74.75% | -62.11% |
| Q4 FY2024Period end 2024-12-31 | $7.19M | +84.67% | +187.20% |
| Q3 FY2024Period end 2024-09-30 | $3.89M | -19.91% | +76.77% |
| Q2 FY2024Period end 2024-06-30 | $4.86M | -85.34% | +121.24% |
| Q1 FY2024Period end 2024-03-31 | $33.16M | +1224.44% | +1079.14% |
| Q4 FY2023Period end 2023-12-31 | $2.50M | +13.66% | -20.85% |
| Q3 FY2023Period end 2023-09-30 | $2.20M | +0.24% | +30.25% |
| Q2 FY2023Period end 2023-06-30 | $2.20M | -21.86% | -45.43% |
| Q1 FY2023Period end 2023-03-31 | $2.81M | -11.10% | -35.23% |
| Q4 FY2022Period end 2022-12-31 | $3.16M | +87.05% | N/A |
| Q3 FY2022Period end 2022-09-30 | $1.69M | -58.00% | N/A |
| Q2 FY2022Period end 2022-06-30 | $4.03M | -7.25% | N/A |
| Q1 FY2022Period end 2022-03-31 | $4.34M | N/A | N/A |
| Q4 FY2021Period end 2021-12-31 | $0 | N/A | N/A |
| Q3 FY2021Period end 2021-09-30 | $0 | N/A | N/A |
| Q2 FY2021Period end 2021-06-30 | $0 | N/A | N/A |
| Q1 FY2021Period end 2021-03-31 | $0 | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
